NEOS Investment Management LLC
Q1 2024 13F-HR Holdings
Net value change ($000)
+557,815
(52.8%)
New positions
75
Sold out positions
18
Turnover %
2.4%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NVDA | 51,370 | 156.2% |
| MSFT | 39,333 | 51.2% |
| AMZN | 25,654 | 64.9% |
| META | 21,316 | 78.5% |
| AAPL | 16,128 | 20.4% |
| GOOGL | 11,492 | 51.7% |
| LLY | 11,490 | 155.5% |
| AVGO | 10,451 | 43.4% |
| BRK-B | 10,155 | 110.3% |
| LIN | 10,067 | 302.5% |
Top Reduces (Value $000, Stocks/ETFs)
| VTWO | -12,537 | -100.0% |
| TSLA | -1,938 | -7.7% |
| BA | -927 | -26.5% |
| SPLUNK INC | -848 | -100.0% |
| PDD | -625 | -19.4% |
| ImmunoGen, Inc. | -523 | -100.0% |
| CymaBay Therapeutics, Inc. | -359 | -100.0% |
| GS | -352 | -10.6% |
| CHTR | -347 | -14.2% |
| IDCC | -318 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|